| Name | Address | City |
|---|---|---|
| RPMC – Richmond Private Methadone Clinic | 4926 W Broad St | Richmond |
| New Season Treatment Center – Southside | 9609 Jefferson Davis Highway | Richmond |
| FCCR Southlake | 905 Southlake Blvd UNIT C | Richmond |
| New Season Treatment Center – Richmond | 2217 East Franklin Street | Richmond |
| FCCR Radford | 4906 Radford Ave | Richmond |
| VA Hospital | 1201 Broad Rock Boulevard | Richmond |
| Richmond Methadone Clinic | 15 West Cary St. | Richmond |
| Human Resources, Inc. | 15 W Cary Street | Richmond |
| BrightView Midlothian | 5001 W Village Green Dr #205 | Midlothian |
| Crossroads Petersburg | 10543 S Crater Road | Petersburg |
| BHG Glen Allen Treatment Center | 13100 Mountain Rd | Glen Allen |
No results found!
Medication treatment for opioid use disorder in Richmond, Virginia
Richmond sits at the center of one of Virginia’s most active regions for opioid use disorder (OUD) treatment, with both clinic-based and office-based care available across the city and neighboring Henrico County. That matters because the three medications used to treat OUD, methadone, buprenorphine (including Suboxone), and naltrexone (including Vivitrol), are not all dispensed the same way or in the same place. The listings above show providers serving the Richmond area. This page explains what those options are, how to pay for them, and how to take the first step. If you need help now, call a provider on this page or the helpline.
Your medication options and where each one is available
There are three FDA-approved medications for opioid use disorder, and where you get each one depends on the medication.
Methadone is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy. An OTP is the setting most people picture as a methadone clinic: you receive your dose there, with take-home doses added over time as treatment stabilizes. Methadone is a full opioid agonist and is often effective for people using high-potency fentanyl.
Buprenorphine, including buprenorphine-naloxone films and tablets sold as Suboxone and the monthly extended-release injection Sublocade, can be prescribed in a doctor’s office and filled at a pharmacy, or provided inside an OTP. This office-based option is called office-based opioid treatment (OBOT). Buprenorphine is a partial agonist with a ceiling effect that lowers overdose risk compared with full agonists.
Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider and is not a controlled substance. It blocks opioid effects, but treatment starts only after you have stopped using opioids for a set time.
Choosing among them is a decision to make with a clinician. If you want to weigh the trade-offs first, see how methadone and Suboxone compare or read more about how methadone works.
Starting treatment: what the first visit looks like
The first step is an intake assessment, where a provider reviews your history and, with you, decides on a medication and a starting plan. Some Richmond-area programs offer same-day or walk-in starts; the listings and the helpline can tell you who does. Bring an ID and any insurance information if you have them, though lack of either should not stop you from calling.
One timing note matters if you have been using fentanyl. Starting buprenorphine too soon after fentanyl can trigger sudden, severe withdrawal, known as precipitated withdrawal, so a clinician plans the timing of your first dose with you. This is manageable and worth asking about directly. You can read more about treatment when fentanyl is involved and about opioid use disorder treatment generally.
Take-home doses, telehealth, and the current rules
Federal rules updated in 2024 (a revision of 42 CFR Part 8) expanded take-home methadone, up to a 28-day supply for patients who are stable in treatment, with the program deciding eligibility based on your progress. The same update allowed treatment to start by telehealth and removed older barriers to getting admitted, including the prior requirement of a one-year history of opioid use before admission.
As of July 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit. Those flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider. Methadone for OUD is still started and dispensed through an OTP, though some programs can begin treatment with a video visit. If you are transferring into Richmond or restarting after a gap, ask a program directly about guest dosing and take-home eligibility, and see why staying at a steady dose supports long-term treatment.
Paying for treatment in Richmond
Virginia Medicaid, known as Cardinal Care, covers all three OUD medications through its Addiction and Recovery Treatment Services (ARTS) benefit, which the Department of Medical Assistance Services (DMAS) launched in 2017. ARTS covers medication in both OTP and office-based settings and built a network of DMAS-credentialed Preferred OBOT sites across the Commonwealth. Cardinal Care is delivered through managed care plans including Aetna Better Health, Anthem HealthKeepers Plus, Molina, Sentara, and UnitedHealthcare Community Plan. Private insurance, Medicare, and self-pay are also accepted at many programs, and some offer sliding-scale fees. Providers on this page can confirm what they take before your first visit.
The overdose picture in Richmond, and where it is heading
Richmond saw real improvement recently. Preliminary data reported by the Richmond and Henrico Health Districts (RHHD) show the City of Richmond had a 40 percent drop in drug overdose deaths and a 46 percent drop in opioid overdose deaths in 2024 compared with 2023 (RHHD, August 2025). Statewide, Virginia recorded 1,548 overdose deaths in 2024, down 37 percent from 2023, with fentanyl and related drugs still involved in about 68 percent of them (Virginia Department of Health, 2026). The year 2023, when the city reported close to 300 overdose deaths, now looks like the local peak.
These are people, not just numbers, and the decline reflects treatment and naloxone reaching more of the community. Effective medication treatment is available locally right now; the listings above and the helpline are the place to start. For background, see our overview of opioid addiction.
Overdose prevention and harm reduction across the city
Richmond has built visible harm-reduction infrastructure, and using it is not a barrier to treatment; the two work together. Naloxone, the medication that reverses an opioid overdose, is available over the counter, at pharmacies under Virginia’s statewide standing order, and free through community programs. RHHD dispenses naloxone at its Cary Street and Henrico West clinics and resource centers, and the City of Richmond operates harm-reduction vending machines offering free naloxone and fentanyl test strips around the clock. Virginia Commonwealth University’s Rams in Recovery program runs mobile naloxone distribution as well. Free REVIVE! trainings, Virginia’s overdose-response and naloxone education program run through the Department of Behavioral Health and Developmental Services, teach anyone how to respond. Virginia’s Good Samaritan protections exist to encourage calling 911 during an overdose. A return to use is a common, manageable part of recovery, not a failure, and carrying naloxone is a reasonable step for anyone close to someone using opioids. See more on preventing and responding to overdose.
Pregnancy, the justice system, and other specific situations
Some Richmond residents come to treatment under particular circumstances. For pregnant patients, methadone or buprenorphine is the recommended standard of care, and starting or staying in treatment is what protects both parent and baby; a care team can plan for neonatal opioid withdrawal syndrome (NOWS) and a Plan of Safe Care. Treatment is medical care, and fear of reporting should not keep anyone from seeking it. People entering care through a drug court, probation, a hospital referral after an overdose, or reentry after incarceration can ask a program whether it accepts their referral source and can provide documentation of attendance. Richmond coordinates much of this work through the Richmond Opioid Task Force, which brings together the city, RHHD, the Richmond Behavioral Health Authority, and treatment and harm-reduction partners. For families, see our guidance on methadone and pregnancy and supporting a loved one in treatment.
Common questions about treatment in Richmond
Do I have to go to a clinic every day?
Not necessarily. Methadone starts with more frequent visits, but federal rules updated in 2024 allow up to 28 days of take-home doses for patients who are stable, decided by the program. Buprenorphine and naltrexone are often managed with regular office visits and pharmacy pickups rather than daily attendance.
Can I start Suboxone by phone?
In many cases, yes. As of July 2026, buprenorphine can be started through telehealth, including audio-only visits, without a prior in-person appointment. These rules run through the end of 2026 and are being finalized, so confirm with a provider.
What is the difference between methadone and Suboxone?
Methadone is a full opioid agonist dispensed only through an opioid treatment program. Suboxone contains buprenorphine, a partial agonist with a lower overdose risk, and can be prescribed in an office and filled at a pharmacy. Neither is better for everyone; the right fit is a decision for you and a clinician. Here is a fuller comparison.
Will Medicaid cover it?
Virginia’s Cardinal Care Medicaid program covers all three medications through the ARTS benefit in both clinic and office settings. Coverage details depend on your managed care plan, so confirm with the provider you choose.
Is long-term medication treatment a problem?
No. Staying on medication for an extended period is legitimate, effective care, not an unfinished step or a crutch. Many people do best on ongoing treatment. You can read about how and when treatment ends when that time comes.
Last reviewed and disclosures
Last reviewed July 2026.
Sources
- Richmond and Henrico Health Districts, overdose prevention news release, August 2025.
- Virginia Department of Health, Drug Overdose Data, 2026.
- Virginia Department of Medical Assistance Services (DMAS), Addiction and Recovery Treatment Services (ARTS) and Cardinal Care.
- Virginia Department of Health, Statewide Standing Order for Naloxone and Other Opioid Reversal Agents.
- Virginia Department of Behavioral Health and Developmental Services (DBHDS), REVIVE! program.
- City of Richmond, Office of Opioid and Substance Use Response, and the Richmond Opioid Task Force.
- SAMHSA and DEA, 42 CFR Part 8 (2024) and buprenorphine telemedicine rules, verified July 2026.
Methadone Centers is not a treatment provider and does not provide medical advice. The information here is educational and does not replace care from a licensed clinician. Decisions about medication and treatment should be made with a qualified provider.
The helpline connection on this site may be answered by a sponsored treatment provider. Using it is free and carries no obligation.